Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice

Abstract

The mouse mutant mnd2 (motor neuron degeneration 2) exhibits muscle wasting, neurodegeneration, involution of the spleen and thymus, and death by 40 days of age1,2. Degeneration of striatal neurons, with astrogliosis and microglia activation, begins at around 3 weeks of age, and other neurons are affected at later stages3. Here we have identified the mnd2 mutation as the missense mutation Ser276Cys in the protease domain of the nuclear-encoded mitochondrial serine protease Omi (also known as HtrA2 or Prss25). Protease activity of Omi is greatly reduced in tissues of mnd2 mice but is restored in mice rescued by a bacterial artificial chromosome transgene containing the wild-type Omi gene. Deletion of the PDZ domain partially restores protease activity to the inactive recombinant Omi protein carrying the Ser276Cys mutation, suggesting that the mutation impairs substrate access or binding to the active site pocket. Loss of Omi protease activity increases the susceptibility of mitochondria to induction of the permeability transition, and increases the sensitivity of mouse embryonic fibroblasts to stress-induced cell death. The neurodegeneration and juvenile lethality in mnd2 mice result from this defect in mitochondrial Omi protease.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1: Genetic and physical map of the mnd2 region.
Figure 2: Ser276Cys mutation in Omi.
Figure 3: Effect of the Ser276Cys mutation on the protease activity of Omi.
Figure 4: Structural determinants of Omi activity.
Figure 5: Sensitivity of mnd2 MEFs to stress-induced cell death.
Figure 6: Ca2+ pulsing-induced mitochondrial membrane permeabilization in mnd2 MEFs.

References

  1. 1

    Jones, J. M. et al. mnd2: a new mouse model of inherited motor neuron disease. Genomics 16, 669–677 (1993)

    CAS  Article  Google Scholar 

  2. 2

    Weber, J. S. et al. High-resolution genetic, physical, and transcript map of the mnd2 region of mouse chromosome 6. Genomics 54, 107–115 (1998)

    CAS  Article  Google Scholar 

  3. 3

    Rathke-Hartlieb, S. et al. Progressive loss of striatal neurons causes motor dysfunction in MND2 mutant mice and is not prevented by Bcl-2. Exp. Neurol. 175, 87–97 (2002)

    CAS  Article  Google Scholar 

  4. 4

    Jang, W. et al. Comparative sequence of human and mouse BAC clones from the mnd2 region of chromosome 2p13. Genome Res. 9, 53–61 (1999)

    CAS  PubMed  PubMed Central  Google Scholar 

  5. 5

    Jang, W., Weber, J. S., Bashir, R., Bushby, K. & Meisler, M. H. Aup1, a novel gene on mouse chromosome 6 and human chromosome 2p13. Genomics 36, 366–368 (1996)

    CAS  Article  Google Scholar 

  6. 6

    Jang, W., Weber, J. S., Harkins, E. B. & Meisler, M. H. Localization of the rhotekin gene RTKN on the physical maps of mouse chromosome 6 and human chromosome 2p13 and exclusion as a candidate for mnd2 and LGMD2B. Genomics 40, 506–507 (1997)

    CAS  Article  Google Scholar 

  7. 7

    Jang, W., Weber, J. S., Tokito, M. K., Holzbaur, E. L. & Meisler, M. H. Mouse p150Glued (dynactin 1) cDNA sequence and evaluation as a candidate for the neuromuscular disease mutation mnd2. Biochem. Biophys. Res. Commun. 231, 344–347 (1997)

    CAS  Article  Google Scholar 

  8. 8

    Ji, W. et al. DQX1, an RNA-dependent ATPase homolog with a novel DEAQ box: expression pattern and genomic sequence comparison of the human and mouse genes. Mamm. Genome 12, 456–461 (2001)

    CAS  Article  Google Scholar 

  9. 9

    Li, W. et al. Structural insights into the pro-apoptotic function of mitochondrial serine protease HtrA2/Omi. Nature Struct. Biol. 9, 436–441 (2002)

    CAS  Article  Google Scholar 

  10. 10

    Hegde, R. et al. Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction. J. Biol. Chem. 277, 432–438 (2002)

    CAS  Article  Google Scholar 

  11. 11

    Suzuki, Y. et al. A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol. Cell 8, 613–621 (2001)

    CAS  Article  Google Scholar 

  12. 12

    Verhagen, A. M. et al. HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins. J. Biol. Chem. 277, 445–454 (2002)

    CAS  Article  Google Scholar 

  13. 13

    Martins, L. M. et al. The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a reaper-like motif. J. Biol. Chem. 277, 439–444 (2002)

    CAS  Article  Google Scholar 

  14. 14

    van Loo, G. et al. The serine protease Omi/HtrA2 is released from mitochondria during apoptosis. Omi interacts with caspase-inhibitor XIAP and induces enhanced caspase activity. Cell Death Differ. 9, 20–26 (2002)

    CAS  Article  Google Scholar 

  15. 15

    Clausen, T., Southan, C. & Ehrmann, M. The HtrA family of proteases: implications for protein composition and cell fate. Mol. Cell 10, 443–455 (2002)

    CAS  Article  Google Scholar 

  16. 16

    Maurizi, M. R. Love it or cleave it: tough choices in protein quality control. Nature Struct. Biol. 9, 410–412 (2002)

    CAS  Article  Google Scholar 

  17. 17

    Srinivasula, S. M. et al. Inhibitor of apoptosis proteins are substrates for the mitochondrial serine protease Omi/HtrA2. J. Biol. Chem. 278, 31469–31472 (2003)

    CAS  Article  Google Scholar 

  18. 18

    Yang, Q. H., Church-Hajduk, R., Ren, J., Newton, M. L. & Du, C. Omi/HtrA2 catalytic cleavage of inhibitor of apoptosis (IAP) irreversibly inactivates IAPs and facilitates caspase activity in apoptosis. Genes Dev. 17, 1487–1496 (2003)

    CAS  Article  Google Scholar 

  19. 19

    Brustovetsky, N. et al. Increased susceptibility of striatal mitochondria to calcium-induced permeability transition. J. Neurosci. 23, 4858–4867 (2003)

    CAS  Article  Google Scholar 

  20. 20

    Szalai, G., Krishnamurthy, R. & Hajnoczky, G. Apoptosis driven by IP(3)-linked mitochondrial calcium signals. EMBO J. 18, 6349–6361 (1999)

    CAS  Article  Google Scholar 

  21. 21

    Reed, J. C. Cytochrome c: can't live with it—can't live without it. Cell 91, 559–562 (1997)

    CAS  Article  Google Scholar 

  22. 22

    Joza, N. et al. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature 410, 549–554 (2001)

    CAS  Article  Google Scholar 

  23. 23

    Klein, J. A. et al. The harlequin mouse mutation downregulates apoptosis-inducing factor. Nature 419, 367–374 (2002)

    CAS  Article  Google Scholar 

  24. 24

    Walsh, N. P., Alba, B. M., Bose, B., Gross, C. A. & Sauer, R. T. OMP peptide signals initiate the envelope-stress response by activating DegS protease via relief of inhibition mediated by its PDZ domain. Cell 113, 61–71 (2003)

    CAS  Article  Google Scholar 

  25. 25

    Leist, M., Single, B., Castoldi, A. F., Kuhnle, S. & Nicotera, P. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J. Exp. Med. 185, 1481–1486 (1997)

    CAS  Article  Google Scholar 

  26. 26

    Susin, S. A. et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397, 441–446 (1999)

    CAS  Article  Google Scholar 

  27. 27

    Danial, N. N. et al. BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis. Nature 424, 952–956 (2003)

    CAS  Article  Google Scholar 

  28. 28

    Casari, G. et al. Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell 93, 973–983 (1998)

    CAS  Article  Google Scholar 

  29. 29

    Van Dyck, L. & Langer, T. ATP-dependent proteases controlling mitochondrial function in the yeast Saccharomyces cerevisiae. Cell. Mol. Life Sci. 56, 825–842 (1999)

    CAS  Article  Google Scholar 

Download references

Acknowledgements

This work was supported by grants from the National Institutes of Health and the Muscular Dystrophy Association. S.M.S. is a Kimmel scholar. W.J. acknowledges support from the Hearing and Chemical Senses Training Program of the University of Michigan. We thank J. Zhang for help in preparation of MEFs and A. Zervos for the mouse Omi cDNA. We also thank M. Farrer and T. Gasser for the PARK3 DNA samples.

Author information

Affiliations

Authors

Corresponding authors

Correspondence to Miriam H. Meisler or Emad S. Alnemri.

Ethics declarations

Competing interests

The authors declare that they have no competing financial interests.Authors' contributions J.M.J., P.D., S.M.S. and W.J. share equal first authorship and E.S.A. and M.H.M. share equal senior authorship.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Jones, J., Datta, P., Srinivasula, S. et al. Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice. Nature 425, 721–727 (2003). https://doi.org/10.1038/nature02052

Download citation

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing